1. Home
  2. SCLX vs DHAI Comparison

SCLX vs DHAI Comparison

Compare SCLX & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • DHAI
  • Stock Information
  • Founded
  • SCLX 2011
  • DHAI 2007
  • Country
  • SCLX United States
  • DHAI United States
  • Employees
  • SCLX N/A
  • DHAI N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • DHAI
  • Sector
  • SCLX Health Care
  • DHAI
  • Exchange
  • SCLX Nasdaq
  • DHAI NYSE
  • Market Cap
  • SCLX 51.3M
  • DHAI 49.1M
  • IPO Year
  • SCLX N/A
  • DHAI N/A
  • Fundamental
  • Price
  • SCLX $4.06
  • DHAI $0.17
  • Analyst Decision
  • SCLX Strong Buy
  • DHAI
  • Analyst Count
  • SCLX 4
  • DHAI 0
  • Target Price
  • SCLX $396.67
  • DHAI N/A
  • AVG Volume (30 Days)
  • SCLX 103.2K
  • DHAI 1.0M
  • Earning Date
  • SCLX 05-12-2025
  • DHAI 02-14-2025
  • Dividend Yield
  • SCLX N/A
  • DHAI N/A
  • EPS Growth
  • SCLX N/A
  • DHAI N/A
  • EPS
  • SCLX N/A
  • DHAI N/A
  • Revenue
  • SCLX $56,590,000.00
  • DHAI $69,573,000.00
  • Revenue This Year
  • SCLX $115.30
  • DHAI N/A
  • Revenue Next Year
  • SCLX $73.33
  • DHAI N/A
  • P/E Ratio
  • SCLX N/A
  • DHAI N/A
  • Revenue Growth
  • SCLX 21.07
  • DHAI 5.40
  • 52 Week Low
  • SCLX $5.80
  • DHAI $0.12
  • 52 Week High
  • SCLX $80.50
  • DHAI $3.67
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 24.27
  • DHAI 35.50
  • Support Level
  • SCLX $3.60
  • DHAI $0.14
  • Resistance Level
  • SCLX $7.64
  • DHAI $0.20
  • Average True Range (ATR)
  • SCLX 1.21
  • DHAI 0.04
  • MACD
  • SCLX -0.37
  • DHAI 0.01
  • Stochastic Oscillator
  • SCLX 6.67
  • DHAI 36.22

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: